Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1766
Source ID: NCT05599815
Associated Drug: Adx-629
Title: Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Acronym:
Status: WITHDRAWN
Study Results: NO
Results:
Conditions: Nephrotic Syndrome
Interventions: DRUG: ADX-629
Outcome Measures: Primary: Adverse Event (AE) Query, Incidence and severity of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs), From Day 1 to Day 90 | Secondary: Relapse Frequency, Proportion of subjects with one or more relapse(s), as defined by treatment with corticosteroid therapy, From Day 1 to Day 90
Sponsor/Collaborators: Sponsor: Aldeyra Therapeutics, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 0
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2023-01
Completion Date: 2023-05
Results First Posted:
Last Update Posted: 2024-04-17
Locations: Amicis Research Center - Northridge, Northridge, California, 91324, United States|University of Colorado, Aurora, Colorado, 80045, United States|South Florida Research Institute, Lauderdale Lakes, Florida, 33309, United States|Emory University - Pediatric Nephrology, Atlanta, Georgia, 30322, United States|ClinCept, LLC, Bremen, Georgia, 30110, United States|Northwest Louisiana Nephrology, Shreveport, Louisiana, 71101, United States|Nevada Kidney Disease Hypertension Center (NKDHC), Las Vegas, Nevada, 88901, United States|East Carolina University - Nephrology, Greenville, North Carolina, 27834, United States|The Ohio State University (OSU) Wexner Medical Center, Columbus, Ohio, 43004, United States|University of Toledo Medical Center, Toledo, Ohio, 43537, United States|Southern Utah Kidney and Hypertension Center, Saint George, Utah, 84765, United States
URL: https://clinicaltrials.gov/show/NCT05599815

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress